Bio Protocol vs Shentu — how do they compare? Bio Protocol trades at Rp440.59 (market cap Rp1T, Rp164,61M 24h volume), while Shentu trades at Rp1,852 (market cap Rp300,41M, Rp21,88M 24h volume). The key difference: Bio Protocol is far larger — about 3328.8× Shentu's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Shentu's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Shentu for 44 Days on average.
| BIO | CTK | |
|---|---|---|
Market Cap | Rp1T | Rp300,41M |
Volume (24h) | Rp164,61M | Rp21,88M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 162,6M CTK |
Typical Hold Time | 18 Days | 44 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Shentu (CTK) is trading at Rp1,849 with a market cap of Rp301.81 million, showing a bullish overall signal driven by oscillators, while moving averages indicate bearish pressure. Key technical levels place support at Rp1,811 and resistance at Rp1,950. The token's 44-day average hold time suggests moderate holding behavior among investors. No major protocol updates or ecosystem news were noted recently, keeping fundamental developments quiet.
Outlook: CTK presents a cautious buy opportunity with bullish momentum but faces resistance near Rp1,950. Risks include low liquidity and crypto market volatility. Investors should monitor volume trends and regulatory shifts in the Indonesian crypto space, as thin trading could amplify price swings.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Shentu Chain, a security-first, delegated proof-of-stake blockchain, for trustworthy execution of mission-critical applications, including DeFi, NFTs, and autonomous vehicles. Shentu Chain prioritizes cross-chain compatibility, built as a Cosmos Hub with full EVM and Hyperledger Burrow compatibility, as well as compatibility with eWASM and Ant Financial’s AntChain.
Read more on CTK →